SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Massaro, A R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massaro, A R
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Are there indicators of remyelination in blood or CSF of multiple sclerosis patients?

A R Massaro

Institute of Neurology, UCSC Medical School, 00168 Rome, Italy

Knowing the mechanisms and the times of remyelination is not only an intriguing scientific challenge but it has also important consequences on the therapeutic approach to multiple sclerosis (MS). The neural-cell adhesion molecule (N-CAM) shows tempting suggestions about its possible involvement in reparative mechanisms, and, finally, in remyelination. In fact, its levels progressively increase in the cerebrospinal fluid (CSF) of acute MS patients, paralleling the progressive clinical improvement after the attack. Some information is also given about the ciliary neurotrophic factor (CNTF), whose CSF levels were found to be increased in MS patients who were recovering from an acute exacerbation.

Key Words: multiple sclerosis • cerebrospinal fluid • remyelination • biological markers • N-CAM • CNTF • S-100

Multiple Sclerosis, Vol. 4, No. 3, 228-231 (1998)
DOI: 10.1177/135245859800400326
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
R. Dutta, J. McDonough, A. Chang, L. Swamy, A. Siu, G. J. Kidd, R. Rudick, K. Mirnics, and B. D. Trapp
Activation of the ciliary neurotrophic factor (CNTF) signalling pathway in cortical neurons of multiple sclerosis patients
Brain, October 1, 2007; 130(10): 2566 - 2576.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Matejuk, J. Dwyer, A. Zamora, A. A. Vandenbark, and H. Offner
Evaluation of the Effects of 17{beta}-Estradiol (17{beta}-E2) on Gene Expression in Experimental Autoimmune Encephalomyelitis Using DNA Microarray
Endocrinology, January 1, 2002; 143(1): 313 - 319.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
A. I. Flores, B. S. Mallon, T. Matsui, W. Ogawa, A. Rosenzweig, T. Okamoto, and W. B. Macklin
Akt-Mediated Survival of Oligodendrocytes Induced by Neuregulins
J. Neurosci., October 15, 2000; 20(20): 7622 - 7630.
[Abstract] [Full Text] [PDF]

Home page
 JEMHome page
R. M. Ransohoff and C. Trebst
Surprising Pleiotropy of Nerve Growth Factor in the Treatment of Experimental Autoimmune Encephalomyelitis
J. Exp. Med., May 15, 2000; 191(10): 1625 - 1630.
[Full Text] [PDF]


Advertisement